Cochrane Evidence Synthesis and Methods ►

Delayed initiation or reduced initial dose of calcineurin-inhibitors for kidney transplant recipients

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

This review aims to look at the benefits and harms of delayed initiation of CNI or reduced initial CNI dose as initial immunosuppression therapy for KT recipients.

This is a protocol.

Published:

16 November 2022

Authors:

Oliveras L, Lopez-Vargas P, Melilli E, Codina S, Royuela A, Coloma López A, Favà A, Manonelles A, Cruzado JM, Montero N

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Oliveras L, Lopez-Vargas P, Melilli E, Codina S, Royuela A, Coloma López A, Favà A, Manonelles A, Cruzado JM, Montero N. Delayed initiation or reduced initial dose of calcineurin-inhibitors for kidney transplant recipients (Protocol). Cochrane Database of Systematic Reviews 2022, Issue 11. Art. No.: CD014855. DOI: 10.1002/14651858.CD014855.